Literature DB >> 34310822

Influence of fluorine substitution on nonbonding interactions in selected para-halogeno anilines.

Wojciech Pietruś1, Rafał Kurczab2, Justyna Kalinowska-Tłuścik3, Ewa Machalska4, Dominika Golonka5, Małgorzata Barańska6, Andrzej Bojarski7.   

Abstract

A series of 4-halogeno aniline derivatives was studied employing combined theoretical and experimental methods (i.e. crystal structure analysis and vibrational spectroscopies). This simplified model system was selected to shed light on the impact of fluorine substitution on the formation of noncovalent interactions such as halogen bonds (XBs) and hydrogen bonds (HBs), which are key interactions in fluorinated/halogenated drug-protein complex formation. Comparative analysis of three previously reported and five newly determined crystal structures indicated that, in most cases, 2-fluoro and 2,6-difluoro substitution of 4-X anilines increases the ability of adjacent amine to form strong N-H∙∙∙N HBs. Additionally, fluorine substituents in the difluorinated derivatives are competitive and attractive HB and XB acceptors and increase the probability of halogen-halogen contacts. A peculiar observation was made for 4-iodoaniline and 2,6-difluoro-4-iodoaniline, which form distinct interaction patterns compared to the corresponding 4-Cl and 4-Br analogs. The observed intramolecular N-H∙∙∙F interactions lead to additional NH bands in the FT-IR spectra.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  4-halogeno anilines; crystal structure analysis; fluorine substituent; hydrogen and halogen bonds; nonbonding interactions

Year:  2021        PMID: 34310822     DOI: 10.1002/cphc.202100383

Source DB:  PubMed          Journal:  Chemphyschem        ISSN: 1439-4235            Impact factor:   3.102


  2 in total

1.  Hydrogen Bonds with Fluorine in Ligand-Protein Complexes-the PDB Analysis and Energy Calculations.

Authors:  Wojciech Pietruś; Rafał Kafel; Andrzej J Bojarski; Rafał Kurczab
Journal:  Molecules       Date:  2022-02-02       Impact factor: 4.411

2.  Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.

Authors:  Michał Abram; Marcin Jakubiec; Katelyn Reeb; Mary Hongying Cheng; Robin Gedschold; Anna Rapacz; Szczepan Mogilski; Katarzyna Socała; Dorota Nieoczym; Małgorzata Szafarz; Gniewomir Latacz; Bartłomiej Szulczyk; Justyna Kalinowska-Tłuścik; Kinga Gawel; Camila V Esguerra; Elżbieta Wyska; Christa E Müller; Ivet Bahar; Andréia C K Fontana; Piotr Wlaź; Rafał M Kamiński; Krzysztof Kamiński
Journal:  J Med Chem       Date:  2022-08-19       Impact factor: 8.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.